NCT05495308View on ClinicalTrials.gov

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study."

CompletedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

May 1, 2022

Conditions
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage IIIDistant MetastasisLocal Recurrence of Malignant Tumor of Rectum
Interventions
PROCEDURE

neoadjuvant treatment

We study the number of patients who achive a complete pathological response after neoadjuvant treatment with radiochemotherapy.

Trial Locations (1)

Unknown

Hospital La Princesa, Madrid

All Listed Sponsors
lead

Hospital San Carlos, Madrid

OTHER

NCT05495308 - "Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study." | Biotech Hunter | Biotech Hunter